A epidemia da aids: Impacto social, científico econômico e perspectivas

Estudos Avancados

Volumn 22, Issue 64, 2008, Pages 73-94

  Greco, Dirceu B ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Economic impact; Epidemic of the aids; Ethics; Perspectives; Scientific impact; Social impact

Indexed keywords

EID: 62449245887     PISSN: 01034014     EISSN: 18069592     Source Type: Journal    
DOI: 10.1590/s0103-40142008000300006     Document Type: Article

References (43)

1. ANGELL, M. The ethics of clinical research in the third world. N. Engl. J. Med., v.337, p.847-9, 1997.
2. ANGELL, M. Investigators' responsibilities for human subjects in developing countries. NEJM, v.13, p.967-8, 2000.
3. BAYER, R.; GOSTIN, L. Legal and ethical issues in AIDS. In: GOTLIEB, M. S. Current topics in AIDS. New York: John Wiley and Sons, 1989. p.263-86.
4. BEECHER, H. K. Ethics and Clinical Research. NEJM, v.274, n.24, p.1354-60, 1996.
5. BERKMAN, A. et al. A critical analysis of the Brazilian response to HIV/ Aids: Lessons learned for controlling and mitigating the epidemic in developing countries. Amer. J. Pub. Healthy, v.95, n.7, p.1162-72, 2006.
6. CONNOR, E. M. et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N. Engl. J. Med., v. 331, p.1173-80, 1994.
7. CONNOR, S. S. Aids: social, legal and ethical issues of the third epidemic. In: Aids: profile of an epidemic. Washington: PAHO, 1989. p.141-58.
8. CDC. Recommendations of the U.S. Public Health service task force on the use of Zidovudine to reduce perinatal transmission of HIV. MMWR, v.43 (n. RR-11), 1994.
9. CONSELHO NACIONAL DE SAÚDE (Brasil). Resolução n. 196, de 10 de outubro de 1996.
10. DECLARAÇÃO UNIVERSAL dos Direitos Humanos. Nova York: ONU, 1948.
11. DECLARATION OF HELSINKI, World Medical Association, Edinburgh 2000. Disponível em: .
12. DECLARATION ON THE TRIPS agreement and public health. DOHA WTO Ministerial 2001. Disponível em: .
13. DISMANTLING THE Helsinki Declaration (Editorial). CMAJ, v.10, p.169, 2003.
14. FAIRCHILD, A. L.; BAYER, R. Uses and abuses of Tuskegee. Science, v.284, p.919-21, 1999.
15. FAUCI, A. S. The Aids Epidemic - Considerations for the 21st Century. NEJM, v.341, n.14, p.1046-50, 1999.
16. FAUCI, A. S. HIV and Aids: 20 years of science. Nature Medicine, v.9, n.7, p.839-43, 2003.
17. GRANGEIRO, A. et al. Sustainability of the Brazilian Policy for access to ARV drugs. Rev. Saúde Pública, v.40 (Suppl.), p.60-9, 2006.
18. GRECO, D. B. Ethique, pauvreté et le Sida. Cahiers Sante, v.2, p.122-9, 1992.
19. GRECO, D. B. Revising the Declaration of Helsinki: Ethics vs. economics or the fallacy of urgency. Can HIV/AIDS Pol. Law Rev., v.5, n.4, p.98-101, 2000.
20. GRECO, D. B. Brazilian policy of universal access to AIDS treatment: sustainability challenges and perspectives. AIDS (Supplement), v.21, p.S37-S45, 2007.
21. INTERNATIONAL ETHICAL GUIDELINES for biomedical research involving human subjects. Geneva: Council for International Organizations of Medical Sciences (CIOMS), 2002. Disponivel em: .
22. KALLINGS, L. O. The first postmodern pandemic: 25 years fo HIV/Aids. J. Int. Med., v.263, p.218-43, 2008.
23. LALLEMANT, M. et al. AZT trial in Thailand. Science, v.270, p.899-900, 1995.
24. LEVINE, R. J. The need to revise the Declaration of Helsinki. Bull. Med. Eth., v.150, p.29-33, 1999.
25. LURIE, P.; GRECO, D. B. US exceptionalism comes to research ethics. The Lancet, p.1117-9, 26 March 2006.
26. LURIE, P.; WOLFE, S. M. Unethical trials of interventions to reduce perinatal transmission of HIV in developing countries. NEJM, v.337, p.1003-5, 1997.
27. MARINS, J. R. P. et al. Dramatic improvement in survival among adult Brazilian AIDS patients. AIDS, v.17, p.1675-82, 2003.
28. OKIE, S. Fighting HIV - Lessons from Brazil. NEJM, v.354, n.19, p.1977-81, 2006.
29. PARKER, R.; CAMARGOS Jr., K. R. Poverty and AIDS: anthropological and sociological aspects. Cad. Saúde Pública, v.16 Suppl. 1, p.89-102, 2000.
30. PHANUPHAK, P. Ethical issues in studies in Thailand of the vertical transmission of HIV. N. Engl. J. Med., v.338, p.834-5, 1998.
31. PORTELA, M. C.; LOTROWSKA, M. Health care to HIV/AIDS patients in Brazil. Rev. Saúde Pública, v.40 Suppl. 1, p.70-9, 2006.
32. ROTHMAN, D. J. The shame of medical research. The New York Review November, n.3, p.60-4, 2000.
33. ROTHMAN, K. J.; MICHELS, K. B. The continuing unethical use of placebo controls. NEJM, v.331, n.6, p.394-8, 1994.
34. SCHÜKLENK, U. Unethical perinatal HIV transmission trials establish bad precedent. Bioethics, v.12, n.4, p.312-9, 1998.
35. SIPRI Yearbook 2008: Armaments, Disarmament and International Security - world military expenditure.
36. STEINBROOK, R. Messagem from Toronto - Deliver AIDS treatment and prevention. NEJM, v.355, n.11, p.1081-8, 2006.
37. SZWARCZWALD, C. L.; CARVALHO, M. F. Estimated numbers of HIV-infected individuals aged 15-49 years in Brazil, 1998. Cad. Saúde Pública, v.16 Suppl. 1, p.135-41, 2000. Disponível em: .
38. TEIXEIRA, P. R. et al. Antiretroviral treatment in resource poor settings: the Brazilian Experience. AIDS, v.18 (Suppl. 3), p.S5-S7, 2004.
39. TRIALS ON TRIAL: The FDA should rethink its rejection of the Declaration of Helsinki (Editorial). Nature, v.453, n.7194, p.427-8, 2008.
40. UNITED NATIONS Declaration of Commitment on HIV/AIDS: review of the Brazilian response, 2001-2005. Rev. Saúde Pública, v.40 Suppl. 1, p.1-120, 2006. (English version ).
41. URBAN POLITIC and Economic Development. Washington: World Bank Report, 1991.
42. WEISS, R. A. HIV and Aids: looking ahead. Nature Medicine, v.9, n.7, p.887-91, 2003.
43. WHO (World Health Organization). Core Health Indicators, 2007 Database. Geneva, 2007.